Medicines with new active substances recommended for marketing authorisation

Of these, 42 had a new active substance which had never been authorised in the European Union (EU) before.

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

European Medicines Agency. (2022). Human medicines: highlights of 2022. Retrieved September 17, 2026, from https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Via StatOrigin, https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ

Copy

MLA

European Medicines Agency. "Human medicines: highlights of 2022." 2022, https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ.

Copy

Chicago

European Medicines Agency. "Human medicines: highlights of 2022." 2022. https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ.

Copy

BibTeX

@misc{ema2022medicineswpt6aj, author = {{European Medicines Agency}}, title = {Human medicines: highlights of 2022}, year = {2022}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ}, note = {Original source: https://www.ema.europa.eu/en/news/human-medicines-highlights-2022. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_M6S01C976QWYFKEGN8SMWPT6AJ.